Pathobiology of pulmonary arterial hypertension and right ventricular failure.
Pathobiology of pulmonary arterial hypertension and right ventricular failure.
复制标题
DOI:
10.1183/09031936.00046612
复制
发表时间:
2012-12
期刊:
影响因子:
--
通讯作者:
Nicolls MR
中科院分区:
文献类型:
--
作者:
Voelkel NF;Gomez-Arroyo J;Abbate A;Bogaard HJ;Nicolls MR
Pulmonary arterial hypertension (PAH) is no longer an orphan disease. There are three different classes of drugs for the treatment of PAH that are currently being used and an increasing number of patients are being treated with a single drug or combination therapy. During the last 25 yrs, new insights into the pathobiology of PAH have been gained. The classical mechanical concepts of pressure, flow, shear stress, right ventricle wall stress and impedance have been complemented with the new concepts of cell injury and repair and interactions of complex multicellular systems. Integrating these concepts will become critical as we design new medical therapies in order to change the prognosis of patients with these fatal diseases. This review intends to summarise recent pathobiological concepts of PAH and right ventricle failure mainly derived from human studies, which reflect the progress made in the understanding of this complex group of pulmonary vascular diseases.
登录
查看更多内容
DOI:
10.1165/rcmb.2010-0371oc
发表时间:
2011-10-01
影响因子:
6.4
作者:
Abe, Kohtaro;Toba, Michie;Oka, Masahiko
通讯作者:
Oka, Masahiko
影响因子:
37.8
作者:
Elliott, C. Gregory;Glissmeyer, Eric W.;Ward, Kenneth
通讯作者:
Ward, Kenneth
DOI:
10.1164/rccm.201006-0869ws
发表时间:
2010-12-15
影响因子:
24.7
作者:
Erzurum, Serpil;Rounds, Sharon I.;Moore, Timothy M.
通讯作者:
Moore, Timothy M.
影响因子:
24.3
作者:
Escribano-Subias, Pilar;Blanco, Isabel;Albert Barbera, Joan
通讯作者:
Albert Barbera, Joan
DOI:
10.1165/rcmb.2010-0412oc
发表时间:
2011-12-01
影响因子:
6.4
作者:
Drake, Jennifer I.;Bogaard, Herman J.;Natarajan, Ramesh
通讯作者:
Natarajan, Ramesh